Cempra, Inc. (CEMP) was a big mover last session, as its shares rose just over 6% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend of the company since Feb 13, as it is now trading above the volatile price range of $12.50 to $13.00.
In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Cempra currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include WuXi PharmaTech (Cayman) Inc. (WX), United Therapeutics Corporation (UTHR) and Aratana Therapeutics, Inc. (PETX). All three carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
CEMPRA INC (CEMP): Free Stock Analysis Report
WUXI PHARMATECH CAYMAN INC (WX): Free Stock Analysis Report
UNITED THERAPEUTICS CP (UTHR): Free Stock Analysis Report
ARATANA THERAPEUTICS INC (PETX): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading